The OmniThera Panomics Profiler provides information on the immune status of the tumour tissue
The OmniThera® Panomics Profiler is our state-of-the-art contribution to precision oncology diagnostics and the treatment of tumor diseases.
It is a comprehensive all-in-one molecular genetic assay that not only analyzes the activity of all 20.000+ human genes, but also simultaneously detects therapeutically relevant oncogenes, tumor suppressor genes, and more.
Applications
- Complete transcriptome analysis and immunohistochemistry of genes playing a key role in important signaling pathways
- Informs about the immune status of the tumor tissue including the responsiveness to checkpoint inhibitors, sensitivity to various chemotherapeutic therapies as well as to natural compounds
- Oncomine Tumor Mutation Load/Burden (TMB) Assay to accurately assess TMB (Mutations/Mb)
- Oncogene Knowledgebase Report, an up-to-date document of worldwide clinical trials and relevant drugs for the patient’s individual genetic fingerprint
Test sample requirements & Turnaround time
FFPE* / fresh tumor sample 
20 business days
* formalin-fixed, paraffin-embedded tissue
Logistics
In Germany, the lead time for transporting fresh tissue or pleural effusions and ascitic fluid is 48 hours before a planned procedure. For FFPE, we will contact the respective pathological institute to arrange the shipping.
